Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > World Health Organisation (WHO) visits Centenary

World Health Organisation (WHO) visits Centenary

Date time 27 March, 2019

Above: Prof Mathew Vadas AO, Executive Director of Centenary, Medical Officer Kefas Samson of the WHO Global TB Programme, Geneva, and Dr Richard Stapledon Chair of the rGLC, WHO Western Pacific Region meet at the Consultant Training for multi-drug resistant tuberculosis.

Emergent drug resistant, especially multi-drug and rifampicin resistant tuberculosis threatens the health security of the Western Pacific region.

In 2017, there were an estimated 114,000 incident cases of multi-drug and rifampicin resistant tuberculosis in the region of whom less than 25 per cent received adequate treatment.

We are delighted to have representatives from the World Health Organisation (WHO) and the regional Green Light Committee (rGLC) with us in Sydney joining with the NHMRC Tuberculosis Centre of Research Excellence (TB CRE) to host a three-day training program.

The Western Pacific Regional Office of World Health Organization End TB unit and the regional Green Light Committee (rGLC) is expanding its pool of consultants providing countries with technical assistance on the programmatic management of drug-resistant tuberculosis (PMDT).

Featuring world-leading experts in the field of tuberculosis control and management the training program is being held at Centenary to develop an adequate and competent pool of regional consultants to provide technical assistance for the programmatic management of multi-drug and rifampicin resistant tuberculosis in the Western Pacific Region.

Tuberculosis occurs in every part of the world. In 2017, the largest number of new TB cases occurred in the South-East Asia and Western Pacific regions, with 62% of new cases, followed by the African region, with 25% of new cases. Ending the TB epidemic by 2030 is among the health targets of the United Nation’s Sustainable Development Goals. WHO has gone one step further and set a 2035 target of 95% reduction in deaths and a 90% decline in TB incidence – similar to current levels in low TB incidence countries today.

WHO MDR-TB Training at Centenary Insttitute
Consultants and Trainers who attended the MDR-TB Training held by World Health Organisation and TB-CRE. The three day event was hosted by Centenary Institute.

Read the WHO Media Release here.

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • New COVID-19 vaccine candidate shows strong protection against multiple variants

    A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.
    News Type: Media release
    Date 18 Jul 2025
  • New route into cells could make gene therapies safer

    Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.
    News Type: Media release
    Date 15 Jul 2025
  • Centenary researchers awarded TIA Pipeline Accelerator Grants

    Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.
    News Type: Research News
    Date 07 Jul 2025
  • Research grant to tackle Alzheimer’s disease

    A research team led by Professor Jennifer Gamble from the Centenary Institute’s Centre for Healthy Ageing has been awarded a prestigious Catalyst Partnership Grant from the Heart Foundation.
    News Type: Research News
    Date 03 Jul 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram